UBS downgraded Blue Owl Capital to Neutral from Buy with a price target of $14, down from $15. The analyst sees see risks to the company’s 2025 target of $1.00 dividend saying the unfavorable backdrop for business development company listings risks a fee rate uplift. The challenging environment puts Blue Owl’s 2025 target at risk, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on OWL:
- CVC preparing to launch IPO as early as next week, FT reports
- Oppenheimer downgrades Blue Owl Capital to Perform on valuation
- Blue Owl Capital downgraded to Perform from Outperform at Oppenheimer
- Wolfe Research initiates the Alternative Asset Managers at Market Overweight
- Blue Owl Capital initiated with an Outperform at Wolfe Research